Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Samsung BioLogics
Pharma
China deals, Daiichi-Merck ADC, Sun Pharma—Fierce Pharma Asia
Trump is reportedly considering limiting drug licensing deals with China. Daiichi and Merck's B7-H3 ADC heads to the FDA. Plus more.
Angus Liu
Sep 11, 2025 8:50pm
Settlement allows Sandoz to launch Eylea biosimilar in late 2026
Sep 9, 2025 10:30am
Samsung Bio inks US contract manufacturing deal worth $1.3B
Sep 9, 2025 8:52am
Lonza posts sales rebound as Samsung Bio's growth rolls on
Jul 23, 2025 10:21am
FDA's response letter salvo sheds light on drug refusal process
Jul 11, 2025 10:15am
Pfizer CEO, Otsuka, Novartis-MSN—Fierce Pharma Asia
Jun 13, 2025 9:18am
